Get the Stockscreener App
1.77
3.28%
-0.06
After Hours:
1.80
0.03
+1.69%
Sutro Biopharma Inc Stock (STRO) Forecast
The Sutro Biopharma Inc (STRO) stock price forecast for the next 30 days is generally positive, with an average analyst price target of $3.9723, representing a +124.42% increase from the current price of $1.77. The highest analyst price target is $5.8425, and the lowest is $2.1022.
Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.
12-Month STRO Price Target
Average 10.10
(+470.41% Upside)
Is Sutro Biopharma Inc (STRO) A Buy Now?
Oscillators
| Name | Value | Action |
|---|---|---|
| RSI(14) | 42.90 | Neutral |
| STOCH(9,6) | 50.57 | Neutral |
| STOCHRSI(14) | 42.12 | Neutral |
| MACD(12,26) | -0.0646 | Buy |
| ADX(14) | 14.61 | Neutral |
| William %R | -57.72 | Neutral |
| CCI(14) | -34.91 | Neutral |
Buy: 1
Sell: 0
Neutral: 6
Summary: Neutral
Moving Averages
| Period | Simple | Exponential |
|---|---|---|
| MA10 |
1.7885
Sell
|
1.822
Sell
|
| MA20 |
1.8803
Sell
|
1.8626
Sell
|
| MA50 |
1.9505
Sell
|
2.0907
Sell
|
| MA100 |
2.6688
Sell
|
2.5165
Sell
|
| MA200 |
3.2853
Sell
|
2.998
Sell
|
Buy: 0
Sell: 10
Neutral: 0
Summary: Sell
According to our latest analysis, STRO could be considered a Strong Sell, with 17 technical analysis indicators signaling 1 Buy signals, 10 signaling Sell signals and 6 Neutral signals. This might not be a good time to consider opening new positions on STRO, as trading bearish markets can be challenging and may result in losses.
- RSI (Relative Strength Index): The RSI(14) value of 42.9 indicates that STRO is neither overbought nor oversold. It suggests a neutral sentiment in the short term.
- STOCH (Stochastic Oscillator): The STOCH value of 50.57 indicates that STRO is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
- STOCHRSI (Stochastic Relative Strength Index): The STOCHRSI value of 42.12 indicates that STRO is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
- ADX (Average Directional Index): The ADX value of The ADX value of 14.61 indicates that there is no clear directional movement, and the market may be ranging or moving sideways.
- CCI (Commodity Channel Index): A CCI(14) value of A CCI(14) value of -34.91 indicates that STRO is not in oversold or overbought territory. It suggests a neutral sentiment in the short term.
Long-term STRO price forecast for 2025, 2030, 2035, 2040, 2045 and 2050
Based on our analysis about Sutro Biopharma Inc financial reports and earnings history, Sutro Biopharma Inc (STRO) stock could reach $3.8437 by 2030, $5.9674 by 2040 and $14.60 by 2050. See the projected annual prices until 2050 of the Sutro Biopharma Inc stock below:
- Sutro Biopharma Inc (STRO) is expected to reach an average price of $3.4253 in 2035, with a high prediction of $3.2079 and a low estimate of $3.4247. This indicates an $93.52% rise from the last recorded price of $1.77.
- Sutro Biopharma Inc (STRO) stock is projected to chart a bullish course in 2040, with an average price target of $6.258, representing an $253.56% surge from its current level. The forecast ranges from a conservative $6.1877 to a sky-high $5.9674.
- Our analysts predict Sutro Biopharma Inc (STRO) to jump 505.15% by 2045, soaring from $10.84 to an average price of $10.71, potentially reaching $10.60. While $10.84 is the low estimate, the potential upside is significant.
- Sutro Biopharma Inc (STRO) stock is expected to climb by 2050, reaching an average of $13.30, a $651.29% jump from its current level. However, a wide range of estimates exists, with high and low targets of $14.60 and $14.53, respectively, highlighting the market's uncertainty.
Sutro Biopharma Inc Stock (STRO) Year by Year Forecast
Sutro Biopharma Inc Stock (STRO) Price Forecast for 2025
Sutro Biopharma Inc Stock (STRO) is expected to reach an average price of $4.182 in 2025, with a high prediction of $7.8358 and a low estimate of $0.5281. This indicates an +136.27% rise from the last recorded price of $1.77.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| March, 2025 | $2.5822 | $2.1022 | $5.8425 | +45.89% |
| April, 2025 | $3.485 | $0.5281 | $4.4298 | +96.89% |
| May, 2025 | $3.5763 | $2.6516 | $3.9997 | +102.05% |
| June, 2025 | $2.6476 | $1.4376 | $4.7679 | +49.58% |
| July, 2025 | $3.0104 | $2.1838 | $4.0623 | +70.08% |
| August, 2025 | $2.7967 | $0.787 | $3.427 | +58.01% |
| September, 2025 | $2.343 | $1.1164 | $3.6633 | +32.37% |
| October, 2025 | $6.4658 | $2.1095 | $7.8358 | +265.30% |
| November, 2025 | $4.0421 | $3.7421 | $7.2624 | +128.37% |
| December, 2025 | $6.9349 | $3.7423 | $7.5148 | +291.80% |
Sutro Biopharma Inc Stock (STRO) Price Forecast for 2026
The predicted value for Sutro Biopharma Inc (STRO) in 2026 is set at an average of $14.67. Estimates vary from a peak of $22.64 to a trough of $6.7015, indicating an +728.86% surge from the present price of $1.77.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2026 | $11.24 | $6.7015 | $13.31 | +535.10% |
| February, 2026 | $17.14 | $10.32 | $19.66 | +868.22% |
| March, 2026 | $21.30 | $14.76 | $22.09 | +1,104% |
| April, 2026 | $18.80 | $15.52 | $22.64 | +961.96% |
| May, 2026 | $19.38 | $13.43 | $20.31 | +995.08% |
| June, 2026 | $14.59 | $14.31 | $20.22 | +724.25% |
| July, 2026 | $14.25 | $12.22 | $16.47 | +705.20% |
| August, 2026 | $13.21 | $12.14 | $15.64 | +646.23% |
| September, 2026 | $12.98 | $12.44 | $14.97 | +633.40% |
| October, 2026 | $13.28 | $11.20 | $13.54 | +650.14% |
| November, 2026 | $16.57 | $12.34 | $17.25 | +836.37% |
| December, 2026 | $13.84 | $13.20 | $17.42 | +681.72% |
Sutro Biopharma Inc Stock (STRO) Price Forecast for 2027
For 2027, Stockscan's Analyst expects the average price target for Sutro Biopharma Inc (STRO) is $9.3807, with a high forecast of $18.74 and a low forecast of $0.0254. This indicates an +429.98% increase from the last price of $1.77.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2027 | $14.05 | $13.10 | $14.81 | +693.94% |
| February, 2027 | $12.63 | $12.56 | $18.74 | +613.51% |
| March, 2027 | $10.96 | $9.4119 | $13.14 | +519.32% |
| April, 2027 | $5.9182 | $4.8382 | $11.30 | +234.36% |
| May, 2027 | $5.0345 | $4.7545 | $6.2313 | +184.43% |
| June, 2027 | $3.5373 | $3.3442 | $5.451 | +99.85% |
| July, 2027 | $3.6536 | $3.0405 | $5.1505 | +106.42% |
| August, 2027 | $2.4499 | $2.1899 | $4.6267 | +38.41% |
| September, 2027 | $0.0227 | $0.0254 | $3.0314 | -98.72% |
| October, 2027 | $0.491 | $0.1207 | $0.4724 | -72.26% |
| November, 2027 | $1.7553 | $0.3079 | $1.7853 | -0.83% |
| December, 2027 | $2.8881 | $1.0115 | $2.9781 | +63.17% |
Sutro Biopharma Inc Stock (STRO) Price Forecast for 2028
In 2028, Sutro Biopharma Inc (STRO) is projected to reach an average price of $2.7475, with a high projection of $4.9158 and a low estimate of $0.5793. This indicates an +55.23% rise from the last price of $1.77.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2028 | $1.6244 | $1.3378 | $2.9447 | -8.23% |
| February, 2028 | $1.4807 | $0.9591 | $1.831 | -16.35% |
| March, 2028 | $3.3435 | $1.1538 | $3.4335 | +88.90% |
| April, 2028 | $3.4998 | $3.0401 | $4.4486 | +97.73% |
| May, 2028 | $3.0326 | $2.6326 | $4.3295 | +71.33% |
| June, 2028 | $3.8689 | $2.6692 | $4.9158 | +118.58% |
| July, 2028 | $2.6952 | $2.4152 | $4.163 | +52.27% |
| August, 2028 | $1.508 | $1.388 | $3.2417 | -14.80% |
| September, 2028 | $1.0343 | $0.5793 | $2.3246 | -41.57% |
| October, 2028 | $1.9906 | $0.584 | $2.2606 | +12.46% |
| November, 2028 | $1.3134 | $0.9334 | $2.6487 | -25.80% |
| December, 2028 | $1.3097 | $1.1997 | $2.2566 | -26.01% |
Sutro Biopharma Inc Stock (STRO) Price Forecast for 2029
The 2029 price forecast for Sutro Biopharma Inc Stock (STRO) is $1.7903 on average, with a high prediction of $3.5353 and a low estimate of $0.0452. This represents an +1.14% increase from the previous price of $1.77.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2029 | $1.2125 | $1.031 | $1.8344 | -31.50% |
| February, 2029 | $1.4088 | $0.7822 | $1.5488 | -20.41% |
| March, 2029 | $0.7851 | $0.7151 | $1.7854 | -55.64% |
| April, 2029 | $0.8814 | $0.0452 | $1.0614 | -50.21% |
| May, 2029 | $0.8958 | $0.1379 | $0.9679 | -49.39% |
| June, 2029 | $0.1595 | $0.4295 | $0.1892 | -90.99% |
| July, 2029 | $1.4468 | $0.2029 | $1.8168 | -18.26% |
| August, 2029 | $1.5796 | $0.4999 | $2.2396 | -10.76% |
| September, 2029 | $1.8259 | $1.4262 | $2.2393 | +3.16% |
| October, 2029 | $0.8087 | $0.5887 | $2.8057 | -54.31% |
| November, 2029 | $1.085 | $0.6153 | $3.5353 | -38.70% |
| December, 2029 | $3.61 | $0.7716 | $3.25 | +103.95% |
Sutro Biopharma Inc Stock (STRO) Price Forecast for 2030
Sutro Biopharma Inc Stock (STRO) is expected to reach an average price of $3.5456 in 2030, with a high forecast of $5.2767 and a low forecast of $1.8145. This signifies an +100.31% surge from the last price of $1.77.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2030 | $3.3543 | $3.3543 | $3.8437 | +89.51% |
| February, 2030 | $2.6418 | $3.108 | $2.548 | +49.25% |
| March, 2030 | $3.2642 | $3.2642 | $2.8555 | +84.42% |
| April, 2030 | $6.1367 | $4.3861 | $5.2767 | +246.70% |
| May, 2030 | $4.896 | $3.7962 | $4.571 | +176.61% |
| June, 2030 | $4.1684 | $4.1884 | $4.8178 | +135.50% |
| July, 2030 | $3.3627 | $3.1809 | $3.2021 | +89.98% |
| August, 2030 | $2.9102 | $3.2902 | $2.1833 | +64.42% |
| September, 2030 | $1.4176 | $1.9176 | $2.2239 | -19.91% |
| October, 2030 | $2.2419 | $1.8145 | $2.4282 | +26.66% |
| November, 2030 | $4.8444 | $2.5088 | $3.7894 | +173.69% |
| December, 2030 | $3.1168 | $3.26 | $3.0762 | +76.09% |
0.27%
3.05%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):